Paul Grayburn MD

Dr. Paul Grayburn holds the Paul J. Thomas Chair in Cardiology at Baylor University Medical Center in Dallas, TX. He has published more than 450 papers and is Associate Editor of the American Journal of Cardiology, JACC Cardiovascular Imaging, and Structural Heart. Dr. Grayburn also has served on multiple committees for the American Society of Echocardiography, including the Task Force for Quantitation of Valvular Regurgitation. His background in both interventional cardiology and echocardiography, including intraoperative TEE during surgical mitral valve repair, gives him a unique insight into percutaneous mitral valve therapies. He is on the Publications Committee for the EVEREST II Trial, and the Steering Committee of the COAPT and APOLLO Trials.

Dr. Paul Grayburn did his general cardiology fellowship under the tutelage of Dr. Anthony N. DeMaria at the University of Kentucky from 1984-1986, followed by a year of interventional cardiology training with Drs. David C. Booth and Cindy Grines. In 1988, he was recruited to the University of Texas Southwestern Medical Center by Dr. James T. Willerson, where he served on the faculty for 15 years. During that time, he was Director of the Echocardiography Laboratories at UT Southwestern, and Chief of Cardiology at the Dallas VA Medical Center, where he also practiced interventional cardiology.

He is currently serving on Steering Committees for several clinical trials in structural heart intervention, including national PI for the CLASP IIF study. His background in both interventional cardiology and echocardiography, including intraoperative TEE during surgical mitral valve repair, gives him a unique insight into percutaneous mitral valve therapies. Dr. Grayburn is a consultant for Abbott Vascular, Edwards, Gore, Medtronic, 4C Medical and receives grant support from the NIH, Abbott Vascular, Boston Scientific, Edwards, Medtronic, Cardiovalve, Neochord and Gore.